Printer Friendly

ROBERT B. ANACONE NAMED SENIOR VICE PRESIDENT, MARKETING AND SALES AT PERSEPTIVE BIOSYSTEMS

 ROBERT B. ANACONE NAMED SENIOR VICE PRESIDENT,
 MARKETING AND SALES AT PERSEPTIVE BIOSYSTEMS
 CAMBRIDGE, Mass., July 16 /PRNewswire/ -- Robert B. Anacone was appointed senior vice president, marketing and sales, for PerSeptive Biosystems, Inc. (NASDAQ: PBIO), it was announced today by Noubar B. Afeyan, Ph.D., president and chief executive officer.
 Anacone comes to PerSeptive from Serono Diagnostics, Inc., a manufacturer and marketer of clinical diagnostic instruments and reagent systems, where he had been vice president, worldwide marketing and sales. From 1987 to 1989, he was vice president, marketing and sales, at Gene-Trak Systems, Inc., a wholly owned subsidiary of Amoco Corporation and a developer of DNA probe technology for use in food processing and clinical diagnostics. Prior to joining Gene-Trak, Anacone served in several managerial capacities at Hybritech, Inc., a clinical diagnostics company. Anacone also has held sales positions at Ortho Diagnositics, Abbott Laboratories and Squibb Pharmaceutical.
 PerSeptive Biosystems designs, manufactures and markets proprietary products and systems for the purification and analysis of biomolecules. These bioseparations products are designed to reduce significantly the time and cost required for the development and manufacture of biopharmaceuticals. The company's current and planned products for the purification and analysis of biomolecules are based on three interrelated core technologies: Perfusion Chromatography(R), ImmunoDetection(tm) and Rational Surface Design(tm).
 Perfusion Chromatography(R) and POROS(R) are registered trademarks and BioCAD(tm), ImmunoDetection(tm) and Rational Surface Design(tm) are trademarks of the company.
 -0- 7/16/92
 /CONTACT: Pam Haslam, vice president of Feinstein Partners, 617-577-8110, for PerSeptive Biosystems/
 (PBIO) CO: PerSeptive Biosystems ST: Massachusetts IN: MTC SU: PER


CN -- NE005 -- 9894 07/16/92 09:22 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Jul 16, 1992
Words:273
Previous Article:NYNEX REPORTS SECOND QUARTER 1992 RESULTS; NET INCOME UP 14 PERCENT FROM A YEAR AGO
Next Article:ALLTEL REPORTS NET INCOME UP 18 PERCENT
Topics:


Related Articles
PERSEPTIVE BIOSYSTEMS ANNOUNCES THIRD QUARTER RESULTS
PERSEPTIVE BIOSYSTEMS, INC. LAUNCHES AUTOPILOT FOR PILOT-SCALE PURIFICATION WITH FIRST SYSTEM SALE
PERSEPTIVE BIOSYSTEMS, INC. ANNOUNCES PUBLIC OFFERING OF TWO MILLION SHARES AT $18 PER SHARE
PERSEPTIVE BIOSYSTEMS ANNOUNCES ACQUISITION OF VESTEC CORPORATION
SEPRAGEN CORPORATION NAMES FREYMEYER NATIONAL SALES MANAGER
PERSEPTIVE BIOSYSTEMS WINS PATENT DISPUTE
PerSeptive Biosystems, Inc. Announces Departure of Robert Anacone
PerSeptive Biosystems Appoints Hewlett-Packard Executive Don Schoeny Senior Vice President, Worldwide Sales, Service and Technical Support
PerSeptive Biosystems Reports Results for Second Fiscal Quarter of 1997; Product Sales up 20%; EPS of $1.02 Includes Gain from ChemGenics Merger
PerSeptive Biosystems Appoints Dr. Marvin Vestal Scientific Fellow

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters